In urothelial carcinoma of the bladder, higher TRMT6/61A expression is accompanied by higher m1A modification on tRF-3b, accompanied by dysregulation of tRF targeted mRNAs. This evidence concerns the gene TRMT6 and bladder transitional cell carcinoma.